AtaiBeckley Inc. (ATAI)
Sept 11, 2026 - ATAI was delisted (reason: acquired by LLY)
7.35
+0.06 (0.82%)
Inactive · Last trade price on Sep 10, 2026
AtaiBeckley Revenue
AtaiBeckley had revenue of $1.70M in the quarter ending June 30, 2026, with 137.00% growth. This brings the company's revenue in the last twelve months to $4.47M, up 93.68% year-over-year. In the year 2025, AtaiBeckley had annual revenue of $4.09M with 1,227.60% growth.
Revenue (ttm)
$4.47M
Revenue Growth
+93.68%
P/S Ratio
609.54
Revenue / Employee
$45,172
Employees
99
Market Cap
2.73B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.09M | 3.78M | 1,227.60% |
| Dec 31, 2024 | 308.00K | -6.00K | -1.91% |
| Dec 31, 2023 | 314.00K | 81.00K | 34.76% |
| Dec 31, 2022 | 233.00K | -20.14M | -98.86% |
| Dec 31, 2021 | 20.38M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ATAI News
- 24 days ago - AtaiBeckley Transcript: EGM 2026 - Transcripts
- 7 weeks ago - AtaiBeckley Quarterly report: Q2 2026 - Filings
- 7 weeks ago - AtaiBeckley Proxy statement: Proxy filing - Filings
- 2 months ago - AtaiBeckley Proxy statement: Proxy filing - Filings
- 2 months ago - The market for psychedelic drugs to treat mental health conditions gets a big buy signal - CNBC
- 2 months ago - AtaiBeckley stock is soaring, and it has Eli Lilly to thank - Invezz
- 2 months ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL) - GlobeNewsWire
- 2 months ago - AtaiBeckley Proxy statement: Proxy filing - Filings